Loading...
Please wait, while we are loading the content...
Similar Documents
What a needle in a haystack !
| Content Provider | Semantic Scholar |
|---|---|
| Author | Campo, Thomas |
| Copyright Year | 2008 |
| Abstract | To the Editor: I read with great interest the report on grand mal seizures being induced by extended-release bupropion hydrochloride (bupropion ER), written by David J. Rissmiller, DO, and Thomas Campo, DO,1 in the October 2007 issue of JAOA—The Journal of the American Osteopathic Association. I too have observed this association between bupropion ER and grand mal seizures. In treating a 42-year-old woman who had been diagnosed with bipolar depression, I prescribed the anticonvulsants lamotrigine (titrated to a final dosage of 200 mg/d) and clonazepam (2 mg/d) over a period of 2 months. Bupropion ER (150 mg/d) was initiated at week 6 and continued for 2 weeks. Upon titration of bupropion ER to 300 mg per day at week 6, the patient experienced a grand mal seizure after 2 days of therapy at the increased dose. All use of bupropion ER was then immediately discontinued. Results of a computed tomographic scan and a lumbar puncture test both proved negative. The patient was then rechallenged within a week with bupropion ER (150 mg/d initially, titrated to 300 mg/d at start of second week). She experienced a second grand mal seizure after 2 days of therapy at the higher dose. The patient had reported no personal history of anorexia nervosa, bulimia, or epilepsy. She had previously been prescribed tramadol hydrochloride (100 mg/d) to relieve chronic shoulder pain, but tramadol had been discontinued 6 weeks prior to her first office visit in the present case. In light of previous reports2-7 that there is a lower incidence of seizures with bupropion ER than with the immediate-release formulation, I feel that the case of my patient and that reported by Drs Rissmiller and Campo1 are clinically important. It is particularly meaningful that the seizures associated with bupropion ER in my patient occurred in conjunction with the use of two anticonvulsants, lamotrigine and clonazepam. I hope that the report by Drs Rissmiller and Campo1 will generate renewed interest in the association between bupropion ER and grand mal seizures. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://watermark.silverchair.com/189.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAcYwggHCBgkqhkiG9w0BBwagggGzMIIBrwIBADCCAagGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMzzMBl5WpOLwmUwYKAgEQgIIBeXQJWAOM5eHJnfW1y_hxtehlE_hEK85Lvxvwelzh_KJvMvl9CFst5M0x4ekyc9t3vJVaYRPMx5ryOVNIZ4G5goI7tgVG4gO8UAMbH7URcg9eiUe6CvXiqrJl5TfF7QVChzmkBCuq82ECdzIEEl_3d2kWka2-kICrwA4oEZIiwQi5hururoqm4GwypPHzrItoTgFSCwEfQyo73r4J2x2Jpeew5x7UihmiJ9X29qxYGUXF9avVEvgRnu5R_nPJ-dGJARmiUHSSiyVjDw-Its_Tnjh05txj1qSTq1ZKGpRc_jIR_YKfE_Wnx8rqzA4pOfxuM_Z_dAAm92Pw7Zn3HurPP2HVfge_KsDarkUGffL65hDQn_hP3jBxyT8wgAlKptLMEErLFAoO4Xe2ZoQCiLab-X_KI3DWlU0tNFpxePDjPlTN9oZXOC4TuT6ZjPlI-GESCO4Cs5MpkWDZdYsSJ0p7YfB8Qsmrsgl25lu6aHTt0Ic1tkK227QHhaBr |
| Alternate Webpage(s) | https://watermark.silverchair.com/189.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAcYwggHCBgkqhkiG9w0BBwagggGzMIIBrwIBADCCAagGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMd0XrMhrTUE-ClMUfAgEQgIIBedsiKOmuQ0W-aHcj74_4Di5qwF6wmCO51c38V8Fr9_V4fLSLt-rFP2_sqfBOxhYZFGwI_-rWh1ywhkD2JV1KNH0bbmvJJuYIkpZEUOKTLWBJVXzSIz95uGpzaJ9oZSIDIQkK7gjF-7yu_osGSgextHgaGEDEAopWg_qqbaTGISzdw2weNQXXJNZepL_iD3jsxFIgExMMrhx-oS4tSe4XzRpUkJ7wC2dDUHveyYkHlmmn5VXP8zsOZ5E9NqOgwkmXsqRyFWkcOKzjbW9lVcLKHDF73gLeBQ8Wjj_hH8ul8v3k1aAVPjMzJOLESBRO5LfL93xS9kB0udQjX78sph-S3aSq3yKT3WEAtYLV-LVB7Clarfrw53IJmqYtL64u5VHcW8vT1zC2WnJKbdkao86vVUvKPQgX7LlKmfHAZ8Sh-4yzSVZi4ckEzRqrVXadl-t2PY8caH1OdIg9axLUQ0-lw3znWUBi6-JsgNaDxmC4Q4arinSrY3KBlEPx |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
